| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |